Whalesbook
Astral's Strong Q4 FY26 Fuels Analyst Optimism
Astral reported a solid fourth quarter for fiscal year 2026, meeting expectations with significant financial growth. Revenue increased by 24.2% year-over-year, while EBITDA rose 26.8%, and net profit grew 26.9%. This marks the third consecutive quarter where Astral has achieved industry-leading volume expansion, highlighting its strong competitive standing. The company's ability to maintain healthy profit margins during this growth period is a key reason for the positive analyst outlook.
Strategic CPVC Resin Integration to Boost Margins
Looking towards fiscal year 2027, Astral's management expects continued strong performance across all its product lines. A major strategic step is the planned backward integration into CPVC resin production, scheduled to begin in Q4FY27. This initiative is projected to significantly increase Astral's share of the CPVC pipe market. The company forecasts that this integration will improve the overall margin for its pipe segment by 200 basis points. This move to secure raw material supply and enhance cost efficiency is central to Astral's growth strategy.
Anand Rathi's Financial Forecasts and Valuation
Anand Rathi projects that Astral's earnings per share will grow at a compound annual rate of 32.3% from FY26 to FY28. The brokerage also anticipates a pre-tax return on invested capital (RoIC) of 31% during the same period, indicating effective use of capital. Based on these forecasts, Anand Rathi has reaffirmed its 'BUY' rating. The target price has been revised to Rs 1,800 per share, down from the previous Rs 2,000. This valuation is based on a price-to-earnings (P/E) multiple of 50 times estimated FY28 earnings, a slight decrease from the earlier 55 times multiple.
Competitive Landscape and Potential Risks
Astral competes in the plumbing and fittings market against companies like Prince Pipes and Supreme Industries. Maintaining its growth leadership against these established players will require ongoing innovation and efficient cost management. The current valuation of 50x FY28 earnings suggests high expectations for Astral's future growth. Investors should be aware that delays in the CPVC resin integration or if it doesn't deliver the expected margin improvements, along with increased competition, could pose risks to the stock's valuation.